Abstract
Multidrug resistant uropathogenic Escherichia coli (MDRUPEC) significantly correlates with recurrent, complicated, and persistent urinary tract infection (UTI). The leading cause of multidrug resistance is the ability of E. coli to form biofilms. The physiological heterogeneity, genetic incontinency, and putative events in gene expression of biofilms render them resistant to antimicrobials and the host immune system. Understanding the determinants of antimicrobial resistance and its correlation with biofilm formations will, therefore, help the development of a better strategy for treating biofilm-associated UTIs. The present study reports on the in vitro detection of biofilm formation among multidrug resistant E. coli strains isolated from urine, the major cause of communal, nosocomial, and food-borne uropathogenic UTI. This is a cross-sectional study conducted in and around Ooty, Nilgiris, India. From the 869 urine samples analyzed for UTI, 29.34% were found to be caused by E. coli. Among this about 23.92% were found to be multidrug resistant. Among the multidrug resistant E. coli isolates, 36.06% of them were potent biofilm producers. E. coli biofilms (n = 22) were resistant to the antibiotics used to treat UTI, namely, amikacin, amoxicillin, ampicillin, cefepime, cefoperazone, cefotaxime, ceftriaxone, cefuroxime, cephalotin, ciprofloxacin, co-trimoxazole, gentamicin, levofloxacin, and nalidixic acid, but sensitive to imipenem and meropenem. All the biofilm producers exhibited motility and hemaggultination but none were positive for hemolysin production. The isolated E. coli biofilms were confirmed by VITEK R2 Compact (bioMerieux, France) and 16S rRNA gene sequencing.
Keywords: Antimicrobials, Biofilms, Escherichia coli, Hemolysis, Multidrug resistance, Urinary tract infection
Introduction
Urinary tract infection (UTI) is one of the most prevalent bacterial infections estimated to affect 150 million people worldwide annually [1, 2]. Among the microorganisms correlated with UTI, uropathogenic Escherichia coli (UPEC) has been reported to significantly contribute to about 90% of community-acquired and 50% of nosocomial (catheter associated) UTIs [3, 4]. Several in vitro studies have demonstrated that the samples collected from patients with persistent and recurrent UTI were biofilm producers [4–6]. In UPEC-associated chronic cystic fibrosis, biofilm-like pods within the intracellular bacterial community (IBC) have been recovered [7]. The prevalence of IBC in children has been reported to be the principal cause of recurrent urinary infections [8]. It has been estimated that the perseverance of E. coli biofilms in the urothelium leads to chronic prostatitis and in some cases it results in pyelonephritis, a deadly condition [5, 9].
In biofilms the bacterial colonies exhibit a corporate behavior where they are embedded in an extracellular matrix made of exopolysaccharides (EPS), nucleic acids, and proteins [10]. The predominant reasons of drug resistance in E. coli biofilms are limiting of the entry of the antibiotics by EPS, horizontal gene transfer of the resistant gene among the bacteria within the biofilms, formation of persister cells, and activation of efflux pumps [11–15]. It has been estimated that the minimum inhibitory concentration of antibiotics to eradicate bacteria enclosed in the biofilms may be 101–104 times greater than the planktonic cells [16]. The elimination of biofilm enclosed bacteria in vivo, however, is still a challenge due to the unavailability of suitable drugs [17].
Several virulence factors contribute to the formation of UPEC biofilms on the bladder. These may include surface appendages such as lipopolysaccharides (LPS), flagella, outer membrane vesicles, pili, flagella, curli fimbriae, siderophore receptors, and secreted toxin [18]. Since inhibiting these virulence factors would not interfere with the planktonic growth of the bacteria that leads to a selective pressure resulting in the evolution of drug resistance, preventing these components would be a good strategy to combat UPEC biofilm infection. In developing novel drugs and alternative approaches for the treatment of biofilm-related infections, it is helpful to identify factors that impair biofilm formation or disturb its structure, based on both physical and biological characteristics.
The present study reports on the in vitro detection of biofilm formation among the multidrug-resistant E. coli strains isolated from urine, the major cause of communal, nosocomial, and food-borne uropathogenic UTI, and to estimate their antibiotic susceptibility and resistant pattern.
Materials and methods
Ethical approval
Ethical approval was obtained from Institutional Ethics Committee, JSS College of Pharmacy, Rockland’s, Ooty, to carry out this cross-sectional study. Urine samples were collected for a period of 1 year (July 2021 to June 2022) from the laboratories in Ooty, Nilgiris district, Tamilnadu, India.
Examination of urine for the identification of E .coli
Macroscopic investigation
Clean catches of midstream urine in a wide mouth container tubes (n = 869) from patients in the age group 3 to 93 with assumptive bacteriuria were examined for their altered color, turbidity, and deposits. The tubes were labeled with age and gender.
Microscopic investigations
The sediments of the centrifuged urine obtained at 2000 rpm for 15 min were examined for the presence of pus cells, blood cells, and crystals.
Staining and biochemical analysis
Urine cultures with colony counts ≥ 105 CFU/ml and ˃ 10 pus cells that were diagnosed positive for significant bateriuria were plated on to Mac Conkey agar (HiMedia, Maharashtra, India) and UTI agar (chromogenic agar) (HiMedia, Maharashtra, India). Both the plates were incubated aerobically for 24 h at 37 °C until adequate growth was observed. Plates with pink colonies on Mac Conkey agar and those with pink to purplish colonies on UTI agar were further conferred by Gram staining and standard biochemical techniques like Indole, Methyl red (MR), Voges Proskauer (VP), Citrate utilization test, and Triple sugar iron agar (TSI).
Antibiotic susceptibility testing
Simple disc diffusion technique was used to identify the antimicrobial resistance pattern of the isolated E. coli as per the instructions of Clinical and Laboratory Standards Institute (CLSI). Five classes of antibiotics, namely, aminoglycosides, cephalosporins, penicillins, fluroquinolones, and carbapenems, were used. The antibiotics used were amikacin (30 μg), amoxicillin (20 μg), ampicillin (10 μg), cefepime (30 μg), cefoperazone (50 μg), cefotaxime (30 μg), ceftriaxone (30 μg), cefuroxime (30 μg), cephalotin (30 μg), ciprofloxacin (5 μg), co-trimoxazole (1.25/23.75 μg), gentamicin (10 μg), imipenem (10 μg), levofloxacin (5 μg), meropenem (10 μg), nalidixic acid (30 μg), and nitrofurantoin (300 μg). The isolates that showed resistance to more than two classes of antibiotics were classified as multidrug resistant.
Detection of biofilm formation
All the MDRUPEC isolates were tested quantitatively and qualitatively for their ability to form biofilms. The 96-well microliter plate assay was conducted to quantify the potent biofilm producer strains amid the isolated MDR E. coli isolates. Overnight cultures of E. coli clinical isolates in LB broth of 0.5 McFarland standard turbidity were prepared. Bacterial suspension (100 μl) was transferred into flat bottomed 96-well polystyrene microtiter plates and incubated for 24 h at 37 °C. Following incubation the extra media were removed and the wells were washed three times with 200 μl of PBS solution and fixed with methanol for 15 min. Air-dried wells were stained with 0.1% crystal violet for 20 min at room temperature. The wells were washed three times with 200 μl of sterile water and dried for 10 min at 37 °C. Glacial acetic acid was added to dissolve the unstained crystal violet. The biofilm biomass was measured at 570 nm using an ELISA reader. Experiments were performed in triplicates, the data obtained were averaged, and the standard deviation estimated.
Qualitative detection of E. coli biofilms was performed by Congo red agar method. The MDRUPEC was streaked on to Congo red agar plates (Hi Media, Mumbai, India). The plates were incubated at 37 °C for 48 h. Appearance of dry crystalline black colonies indicated the biofilm formation and appearance of red colonies indicated nonbiofilm producers.
The strains among the MDR isolates which showed an OD ≥ 0.1 and produced black-color colonies on Congo red agar plates were further confirmed for E. coli by VITEK R2 Compact (bioMerieux, France).
Detection of E. coli biofilm phenotypic virulence factor
Hemolysis assay
Overnight cultures of the isolated E. coli biofilms (n = 22) in LB broth of 0.5 McFarland standard turbidity were streaked on to agar plates containing 5% sheep blood agar and incubated at 37 °C for 24 h. Appearance of green color surrounding the colonies indicates alpha hemolysis due to the production of hemolysin that can digest red blood cells.
Hemaggultination assay
Direct hemaggultination test slide method was employed. At room temperature one drop of 3% RBC suspension was added to a drop of E. coli biofilm broth culture (n = 22) and the slide was rocked for about 5 min. Appearance of clumping indicated positive for hemaggultination. Mannose sensitive hemaggultination was analyzed by adding a drop of 2% (w/v) D-mannose to a drop of 3% RBC suspension and a drop of E. coli biofilm culture in a parallel set. Absence of clumping indicated positive for D-mannose sensitive hemaggultination.
Motility assay
E. coli biofilm swimming and swarming motility was analyzed as reported by Wu [19]. Overnight cultures of E. coli biofilms (0.5 McFarland standards) were plated on to 0.3% agar plates containing 1% tryptone (w/v) and 0.25% NaCl (w/v) using a sterile tooth pick to estimate the swimming motility. The plates were incubated at 37 °C for 24 h. Swarming motility was detected by plating the same on to 0.8% glucose (w/v) in 0.5% LB agar plates and incubating it at 37 °C for 24 h. The distance of migration was measured using a caliper in millimeter.
Confirmation of biofilm producers as E. coli by DNA sequencing
The E .coli biofilm which showed an OD of 0.504 ± 0.002 was further confirmed for E. coli with 16S rRNA gene sequencing. DNA isolation from microbial samples was carried out using the Biobee Spin EXpure Microbial DNA isolation kit developed by Bogar Bio Bee stores Pvt Ltd. The PCR product was sequenced using the primers, 5′ AGAGTTTGATCTGGCTCAG 3′ and 5′ TACGGTACCTTGTTACGACTT 3′. Sequencing reactions were performed using a ABI PRISM® BigDyeTM Terminator Cycle Sequencing Kit with AmpliTaq® DNA polymerase (FS enzyme) (Applied Biosystems). Single-pass sequencing was performed on each template using the below 16s rRNA universal primers. The fluorescent-labeled fragments were purified from the unincorporated terminators using the ethanol precipitation protocol. The samples were suspended in distilled water and subjected to electrophoresis in an ABI 3730xl sequencer (Applied Biosystems). The program, MUSCLE 3.7, was used for multiple alignments of sequences (Edgar 2004). The program PhyML 3.0 aLRT was then used for phylogeny analysis using HKY85 as the substitution model.
Statistical analysis
Descriptive statistical analysis like mean with ranges and percentages was carried out using Microsoft Excel and SPSS software version 22.0 (IBM Crop, Armonk, NY, USA). The data are presented as mean ±SD from three experiments.
Results
Examination of urine for identification of E .coli
From 869 urine samples analyzed for UTI, 404 had no significant growth and 255 (29.34%) samples produced pink colonies on Mac Conkey agar and pink to purplish colonies on chromogenic UTI agar. On verification using gram staining, all the isolates (n = 255) appeared as pink-colored negative rods under microscope. Further confirmation using biochemical test showed that all the isolates (n = 255) were positive for Indole, Methyl red, and Catalase and negative for Voges Proskauer, Citrate utilization, TSI, Urease, and Oxidase. The results obtained thus reveal that among the microorganisms causing UTI, E. coli is the organism identified.
Table 1 shows the distribution of UTI based on gender. The data reveal that females, 171 (67.06%), were more prone to UTI than males 84 (32.94%). Figure 1 shows the distribution of E. coli UTI in relation to age and gender. The data reveal that based on age, adults are more prone to E. coli UTI infection. The data also reveal that when compared to females in the reproductive age, UTI infections are predominant in adults.
Table 1.
Distribution of UTI based on gender
| S. no | n = 255 | Percentage | |
|---|---|---|---|
| 1 | Female | 171 | 67.06% |
| 2 | Male | 84 | 32.94% |
Significance of the findings are in bold
Fig. 1.
Distribution of E. coli UTI based on age and gender
Antibiotic susceptibility testing
Table 2 shows the percentage of MDR and non MDR among E. coli isolates. The data reveal that out of the 255 UPEC isolates, 61 (23.92%) were resistant to more than two classes of antibiotic, namely, aminoglycosides, cephalosporins, penicillins, and fluroquinolones, and 194 (76.08%) were non multidrug resistant. All the MDR-resistant UPEC strains show resistance to amikacin (8.20%), amoxicillin (100%), ampicillin (100%), cefepime (100%), cefoperazone (100%), cefotaxime (100%), ceftriaxone (100%), cefuroxime (100%), cephalotin (100%), ciprofloxacin (78.68%), co-trimoxazole (88.52%), gentamicin (67.27%), levofloxacin (83.60%), nalidixic acid (93.44%), and nitrofurantoin (14%). These strains, however, were sensitive to meropenem and imipenem. The non-multidrug-resistant strains are found to be sensitive to all the above antibiotics.
Table 2.
Percentage of MDR and non MDR among E. coli isolates
| S. no | n = 255 | Percentage | |
|---|---|---|---|
| 1 | E. coli MDR | 61 | 23.92% |
| 2 | E. coli non MDR | 194 | 76.08% |
Significance of the findings are in bold
Detection of biofilms
MDRUPEC isolates (61) were quantitatively screened for their ability to produce biofilms on polystyrene microtiter plate. Table 3 shows the data obtained on the formation of biofilms. The data reveal that only 22 (36.67%) isolates produce biofilms with OD ranging from 0.222 to 0.504, and 39 (63.93%) do not produce biofilms. Qualitative studies reveal 22 isolates that show OD greater than 0.200 produce dry black crystalline colonies on Congo red plates, indicating biofilm production (Fig. 2).
Table 3.
Formation of biofilm on polystyrene by MDR UPEC
| MDR UPEC |
OD570 ± SD | Biofilm formation | MDR UPEC |
OD570 ± SD | Biofilm formation |
|---|---|---|---|---|---|
| 1 | 0.222 ± 0.001 | positive (low grade) | 32 | 0.343 ± 0.00 | Positive (low grade) |
| 2 | 0.041 ± 0.002 | Negative | 33 | 0.018 ± 0.001 | Negative |
| 3 | 0.064 ± 0.001 | Negative | 34 | 0.032 ± 0.001 | Negative |
| 4 | 0.063 ± 0.001 | Negative | 35 | 0.023 ± 0.002 | Negative |
| 5 | 0.003 ± 0.001 | Negative | 36 | 0.024 ± 0.002 | Negative |
| 6 | 0.080 ± 0.001 | Negative | 37 | 0.033 ± 0.002 | Negative |
| 7 | 0.317 ± 0.001 | positive (low grade) | 38 | 0.245 ± 0.004 | Positive (low grade) |
| 8 | 0.051 ± 0.001 | Negative | 39 | 0.051 ± 0.003 | Negative |
| 9. | 0.044 ± 0.002 | Negative | 40 | 0.204 ± 0.003 | Positive (low grade) |
| 10 | 0.238 ± 0.001 | positive (low grade) | 41 | 0.036 ± 0.003 | Negative |
| 11 | 0.245 ± 0.001 | positive (low grade) | 42 | 0.022 ± 0.002 | Negative |
| 12 | 0.065 ±0.001 | Negative | 43 | 0.224 ± 0.004 | Positive (low grade) |
| 13 | 0.207 ± 0.002 | positive (low grade) | 44 | 0.024 ± 0.003 | Negative |
| 14 | 0.260 ± 0.002 | positive (low Grade) | 45 | 0.332 ± 0.003 | Positive (low grade) |
| 15 | 0.342 ± 0.001 | positive (low grade) | 46 | 0.283 ± 0.002 | Positive (low grade) |
| 16 | 0.227 ± 0.002 | Positive (low grade) | 47 | 0.286 ± 0.003 | Positive (low grade) |
| 17 | 0.333 ± 0.002 | Positive (low grade) | 48 | 0.074 ± 0.003 | Negative |
| 18 | 0.094 ± 0.002 | Negative | 49 | 0.215 ± 0.001 | Positive (low grade) |
| 19 | 0.037 ± 0.001 | Negative | 50 | 0.032 ± 0.001 | Negative |
| 20 | 0.205 ± 0.001 | Positive (low grade) | 51 | 0.016 ± 0.003 | Negative |
| 21 | 0.062 ± 0.002 | Negative | 52 | 0.033 ± 0.004 | Negative |
| 22 | 0.018 ± 0.001 | Negative | 53 | 0.028 ± 0.003 | Negative |
| 23 | 0.032 ± 0.001 | Negative | 54 | 0.045 ± 0.002 | Negative |
| 24 | 0.071 ± 0.001 | Negative | 55 | 0.033 ± 0.022 | Negative |
| 25 | 0.417 ± 0.001 | Positive (moderate) | 56 | 0.016 ± 0.003 | Negative |
| 26 | 0.091 ± 0.001 | Negative | 57 | 0.245 ± 0.004 | Positive (low grade) |
| 27 | 0.504 ± 0.002 | Positive (moderate) | 58 | 0.015 ± 0.004 | Negative |
| 28 | 0.355 ± 0.001 | Positive (low grade) | 59 | 0.065 ± 0.004 | Negative |
| 29 | 0.047 ± 0.001 | Negative | 60 | 0.026 ± 0.002 | Negative |
| 30 | 0.023 ± 0.001 | Negative | 61 | 0.042 ± 0.002 | Negative |
| 31 | 0.063 ± 0.002 | Negative |
Fig. 2.

Dry black crystalline colonies of UPEC biofilm on Congo red agar plate
Table 4 shows the distribution of biofilms in relation to gender. The data reveal that the majority of biofilm-producing isolates are from females (63.64%) compared to males (36.36%). The most robust biofilm was isolated from a female in the reproductive age group with an OD of 0.504 ± 0.002 (Table 3). One of the biofilm forming isolates (n = 22) was from an infant female. Figure 3 shows the distribution of biofilms in relation to age and gender. No biofilm formation was observed in males in the age group 11–35 years. Further, the incidence of biofilm formation is more among adults (35–95 years).
Table 4.
Distribution of biofilms in relation to gender
| S. no | n = 22 | Percentage | |
|---|---|---|---|
| 1 | Female | 14 | 63.64% |
| 2 | Male | 8 | 36.936% |
Significance of the findings are in bold
Fig. 3.
Distribution of biofilms in relation to age and gender
Table 5 shows the comparison between biofilm and non-biofilm producers on resistance pattern. The data reveal that the biofilms are resistance to amikacin (9.09%), amoxicillin (100%), ampicillin (100%), cefepime (100%), cefoperazone (13.64%), cefotaxime (100%), ceftriaxone (100%), cefuroxime (100%), cephalotin (5.45%), ciprofloxacin (63.18%), co-trimoxazole (95.65%), gentamicin (63.64%), levofloxacin (3.18%), and nalidixic acid (13.06%). All the 22 biofilm producers and 39 non-biofilm producers, however, are sensitive to imipenem and meropenem. All the UPEC biofilms which showed an OD ≥ 0.1 and produced black-color colonies on Congo red agar plates were confirmed as E. coli by VITEKR 2 Compact (bioMerieux, France).
Table 5.
Comparison of resistance pattern of biofilm and nonbiofilm producers isolated from MDRUPEC
| Antibiotics | Biofilm producer n = 22, n = (%) |
Nonbiofilm producer n = 39, n = (%) |
||
|---|---|---|---|---|
| Sensitive | Resistant | Sensitive | Resistant | |
| (Penicillins) | ||||
| Amoxicillin | 0 | 22 (100) | 0 | 39 (100) |
| Ampicillin | 0 | 22 (100) | 0 | 39 (100) |
| (cephalosporins) | ||||
| Cefepime | 0 | 22 (100) | 0 | 39 (100) |
| Cefoperazone | 19 (86.36) | 3 (13.64) | 27 (69) | 12 (30.8) |
| Cefotaxime | 0 | 22 (100) | 0 | 39 (100) |
| Ceftriaxone | 0 | 22 (100) | 0 | 39 (100) |
| Cefuroxime | 0 | 22 (100) | 0 | 39 (100) |
| Cephalotin | 1 (4.5) | 21 (95.45) | 0 | 39 (100) |
| (aminoglycoside) | ||||
| Amikacin | 20 (91.2) | 2 (9.1) | 36 (92) | 3 (7.9) |
| Gentamicin | 8 (36.36) | 14 (63.63) | 12 (31) | 27(69.23) |
| (quinolone) | ||||
| Ciprofloxacin | 7 (31.8) | 15 (68.18) | 17 (43.6) | 22 (56.4) |
| Levofloxacin | 15 (68.18) | 7 (31.8) | 4 (10) | 35(90) |
| Nalidixic acid | 18 (82) | 4 (18) | 33 (84.6) | 6 (15.4) |
| (carbapenem) | ||||
| Imipenem | 22 (100) | 0 | 39 (100) | 0 |
| Meropenem | 22 (100) | 0 | 39 (100) | 0 |
| (sulfonamides) | ||||
| Co-trimoxazole | 1 (4.5) | 21 (95.45) | 6 (15.4) | 33 (84.6) |
| (macrobid) | ||||
| Nitrofurantoin | 20 (91) | 2 (9) | 37 (95) | 2 (5) |
Detection of E. coli biofilm phenotypic virulence factor
Assessment of hemolysin production of the UPEC biofilms (n = 22) is shown in Fig. 4. The data reveal that none of the isolates produce alpha hemolysis phenotypic virulence on sheep blood agar. In direct hemaggultination test slide method, it was observed that all the UPEC biofilms (n = 22) produce clumping in RBC suspension, indicating positive for hemaggultination. In a parallel study conducted to analyze D mannose sensitive hemaggultination, it was observed that none of the UPEC biofilms (n = 22) produce clumping in the RBC suspension in the presence of D mannose. All the UPEC biofilms (n = 22) showed an average swimming motility of 19.59 ± 0.87 and swarming motility of 27.77 ± 0.94. Levels of swarming motility were higher when compared to swimming motility.
Fig. 4.

Hemolysin production of UPEC biofilm on sheep blood agar
Confirmation of biofilm producer as E. coli by DNA sequencing
Figure 5 shows the phylogenetic tree for the selected E. coli strain. The figure reveals that following PCR amplification and 16S rRNA gene sequencing, a comparison of the 16S -23S ITS region of the biofilm isolate with the non-redundant 16S rRNA sequence (Gene bank, PDB) by using Ribosomal RNA BLAST (PhyMl 3.0 aLRT) reveals the partial sequence of 1192 bp of E. coli biofilm strain has a sequence similarity of 98% with the E. coli strain ISD 16s rRNA gene partial sequence (MIN208184.1). The isolated E. coli biofilm strain, confirmed by 16S rRNA gene sequencing as E. coli, was submitted to the NCBI data bank. It was published with the accession no. 0P74038.
Fig. 5.
Phylogenetic tree for the selected E. coli strain
Discussion
The broad aim of the present study was to determine the incidence of E. coli biofilms among the UTI caused by E. coli and to estimate their antibiotic susceptibility and resistance pattern. In this cross-sectional study, information regarding asymptomatic vs. symptomatic, complicated vs. uncomplicated, and catheter associated vs. healthcare associated was not estimated and discussed. Biofilm formation among the non-multidrug-resistant strains and the ESβL (extended spectrum β lactamase) resistant pattern were also not estimated and analyzed.
From the 869 urine samples analyzed for UTI, the results reveal that 255 (29.35%) of UTI infection are caused by E. coli. A similar study conducted in Karaikudi, India, has reported that the major causative agent of UTI was E. coli (28.09%) followed by Pseudomonas aeruginasa (15.73%), Enterococcus faecalis (14.61%), Staphylococcus aureus (12.3%), Klebsiella pneumoniae (8.9%), and Proteus vulgaris (7.87%) [20]. It was observed that compared to males (32.94%), the incidences of UTI in females are about 67.06% (171/255). A similar observation has been made earlier [21]. Risk factors associated with female UTI, namely, female anatomy, sexual activity, pregnancy, certain types of birth control, and menopause, are the major reasons for this observation [22–24]. In the present study UTI infections are predominant in adults than females in the reproductive age. These conclusions are similar to earlier findings [25, 26]. The relatively high resistance rates of UPEC for cephalosporins and fluroquinolones observed are similar to a recent study carried out in Iran where the resistance levels of UPEC against cephalosporins and fluroquinolones were between 30 and 60% and 15 and 66%, respectively [27, 28]. In this study the resistance to nitrofurantoin was reported as 14%, whereas in a similar study conducted in Hong Kong, a low prevalence of nitrofurantoin resistance was reported [29].
The relatively lower resistance of UPEC for imipenem and meropenem is similar to the studies reported from southern Iraq wherein E. coli isolates were found sensitive to imipenem [30]. Interestingly the antibiotic resistances to cefepime, cefotaxime, ceftazidime, and ofloxacin were found to be higher in Zhejiang city than in Shangai city of China [31]. Antibiotic resistance thus differs from region to region and country to country. Understanding the area-specific data of antibiotic resistance pattern will, therefore, help to design better treatment strategies for different geographical regions, thereby preventing the misuse of antibiotics for treating UPEC infections [18, 32].
It was observed that among the 61 MDR UPEC isolates analyzed for biofilm formation quantitatively by crystal violet staining and qualitatively by Congo red assay, 22 (36.07%) were biofilm producers (Table 3). Our results are slightly different from a previous study conducted in Uganda wherein biofilm formation among the MDR UPEC has been reported as 64% [4]. Also a study conducted in Ningbo, China, has reported that among the 69 E. coli biofilm isolates, 23 were MDR UPEC and 57 isolates were extensively dug resistant (XDR) [33]. Though several studies have proved that antibiotic resistance is attributed to biofilm formation, it was also observed that about 63.93% (39/61) of multidrug-resistant strains were non-biofilm producers. This may be attributed to the ability of E. coli to produce beta-lactamase enzymes such as CTX-M, TEM, and SHV belonging to group A of Ambler categorization (A to D), rendering them resistant to a wide classes of antibiotics, including aminoglycosides, fluoroquinolones, and trimethoprim [20]. In the present study it was observed that the biofilm formation in females is twice as much as males and the most potent biofilm was isolated from a female. Persistence of E. coli biofilm in females is, therefore, the major cause of chronic UTI that leads to pyelonephritis [34]. One of the biofilm forming isolates was from an infant female. E. coli biofilms are thus associated with MDR complicated recurrent and persistent UTI infection in children [35]. In relation to age, it was observed that incidence of biofilm formation was more among adults (Fig. 3). Low levels of immunity and underlying health conditions like diabetics may be the rationale behind this observation [25, 26].
It is also observed that 39 (63.93%) of the multidrug resistant strains are non-biofilm producers. Similar reports have been made by earlier workers [33, 36]. A comparison of resistance pattern of biofilm and non-biofilm producers isolated from MDRUPEC reveals that the biofilm producers are resistant to amikacin (9.1%) cefoperazone (13.64%), cephalotin (5.45%), and levofloxacin (3.18), and nonbiofilm producers are resistant to amikacin (7.9%), cefoperazone (30.8%), cephalotin (100%), and levofloxacin (90%) (Table 5). The wider genetic diversity of virulence and resistance genes may be the rationale behind this observation [37]. The present study reveals that biofilms are highly resistant to almost all the antibiotics regularly used to treat UTI infections but are sensitive to carbapenem class of antibiotics. The inappropriate use of antibiotics is leading cause of drug resistance. Several irrational antibiotic practices in India such as procurement of antibiotics without prescription, over prescription of antibiotics, and failure to adhere to the treatment protocol are the likely reasons for the accelerated spread of microbial resistance. Implementing strict regulations in India regarding drug manufacturing, marketing, and sales could prevent the spread of these MDR strains [38]. A regular surveillance on the prevalence of biofilm formation in E. coli isolates and their antimicrobial resistance should also be evaluated in specific regions before prescribing antibiotics by physicians to prevent the misuse and overuse of antibiotics [33].
None of the isolates (n = 22) produced alpha hemolysis phenotypic virulence factor. Our observation is contradictory to earlier studies wherein UPEC biofilm isolates have been reported to show hemolysis activity important for the pathogenesis in pyelonephritis patients [37, 39]. All the isolates (n = 22) were found positive for hemaggultination. Hemaggultination mediated by type 1 fimbriae initiates the first step in biofilm formation by aiding the initial attachment of bacteria to mucosal epithelium of the urinary tract and kidney [40]. Moreover, all the UPEC biofilms (n = 22) exhibited swimming and swarming motility. Flagellum-mediated motility is crucial for the adherence and virulence on the mucosal epithelium of urinary tract during biofilm formation [41].
Characterization of bacterial species is essential for the accurate and definite identification of microorganisms [42]. Determination of phylogenetic relationship is important to understand the evolution of conservation of a particular gene across microorganisms. In the present study partial sequence of 1192 bp of 16S rDNA was sequenced and used for the identification of the isolated biofilm strain. A comparison of the test sequence with the nonredundant Gene bank collection using BLAST assessment revealed that the E. coli biofilm isolate has 98% sequence similarity with Escherichia coli MIN208184.1, thus, showing that the isolated strain belongs to the genera Escherichia coli. A similar 16S rRNA gene sequence study conducted earlier in India has demonstrated that the majority of biofilm producers isolated from UTI patients had 98% sequence similarity with E. coli KC893339.1 [20]. The isolated E. coli biofilm strain in the present study confirmed by 16S rRNA gene sequencing as E. coli and published with the accession no. OP74038 would be useful for further molecular antibiofilm studies.
Conclusions
UTI caused by multidrug-resistant E. coli and E. coli biofilms is a major clinical concern, both in outpatients and hospital settings. In the present, study we report that not all the MDR-resistant E. coli are biofilm producers. Further, our studies prove that the MDR E. coli isolates (n = 61) and the E. coli biofilms (n = 22) are resistant to the antibiotics normally used to treat UTI. Both the MDR E. coli and E. coli biofilms are sensitive to imipenem and meropenem. The variability of antibiotic-susceptibility pattern reflects the different panels of antibiotics and different protocols used in different hospital and geographical areas. Understanding the antibiotic-resistant pattern would, therefore, help in better selection of antibiotics to treat infections pertaining to different geographical regions. Drug resistance by E. coli biofilms is an inevitable challenge for the successful eradication and prevention of recurrent and persistent infections in humans. The conventional method that attempts to prevent the bacterial growth can lead the development of microbial resistance. Novel methods are, therefore, required to circumvent these growth inhibitory effects. The isolated E. coli biofilm strain confirmed as E. coli by 16S rRNA gene sequencing in the present study will be useful for further molecular and antibiofilm studies. Presently studies are in progress for inhibiting biofilm formation by targeting genes that are involved in quorum sensing, the major mechanism involved in biofilm formation.
Acknowledgements
We acknowledge JSS College of Pharmacy, Udhagamandalam, for their generous support offered for the completion of this study.
Author contributions
A. P. Cardiliya, M. J. N. Chandrasekar, and M. J. Nanjan were responsible for the conceptualization and design. A. P. Cardiliya and M. J. N. Chandrasekar were responsible for collection of data, analysis, and interpretation of the data. M. J. Nanjan contributed in editing and revising the manuscript critically.
Declarations
Ethical approval
Ethical approval was obtained from Institutional Ethics Committee, JSS College of Pharmacy, Rockland’s, Ooty.
Conflict of interest
The authors declare no competing interests.
Footnotes
Responsible Editor: Beatriz Ernestina Cabilio Guth
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Foxman B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin North Am. 2014;28(1):1–13. doi: 10.1016/j.idc.2013.09.003. [DOI] [PubMed] [Google Scholar]
- 2.O'Brien VP, Hannan TJ, Nielsen HV, Hultgren SJ (2016) Drug and vaccine development for the treatment and prevention of urinary tract infections. Microbiol Spectr 4(1). 10.1128/microbiolspec.UTI-0013-2012 [DOI] [PMC free article] [PubMed]
- 3.Boll EJ. Overballe-Petersen S, Hasman H, Roer L, Ng K, Scheutz F, et al. Emergence of enteroaggregative Escherichia coli within the ST131 lineage as a cause of extraintestinal infections. MBio. 2020;11(3):e00353–e00e20. doi: 10.1128/mBio.00353-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Katongole P, Nalubega F, Florence NC, Asiimwe B, Andia I. Biofilm formation, antimicrobial susceptibility and virulence genes of Uropathogenic Escherichia coli isolated from clinical isolates in Uganda. BMC Infect Dis. 2020;20(1):453. doi: 10.1186/s12879-020-05186-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Brian M. Population dynamics of an Escherichia coli ST131 lineage during recurrent urinary tract infection Nat. Commun. 2019;10:3643. doi: 10.1038/s41467-019-11571-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Sanchez CJ, Mende K, Beckius ML, Akers KS, Romano DR, Wenke JC, Murray CK. Biofilm formation by clinical isolates and the implications in chronic infections. BMC Infect. 2013;13(1):47. doi: 10.1186/1471-2334-13-47. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Anderson G, Palermo JJ, Schilling JD, Roth R, Heuser J, Hultgren SJ. Intracellular bacterial biofilm-like pods in urinary tract infections. Science. 2023;301:105–107. doi: 10.1126/science.1084550. [DOI] [PubMed] [Google Scholar]
- 8.Stamm WE. Norrby SR Urinary tract infections: disease panorama and challenges. J Infect Dis. 2001;183(1):S1–S4. doi: 10.1086/318850. [DOI] [PubMed] [Google Scholar]
- 9.Saroj G, Vivek H, Sujata KK, Reddy M. Correlation between biofilm formation of uropathogenic Escherichia coli and its antibiotic resistance pattern. J Evol Med Dent Sci. 2012;1:166–175. doi: 10.14260/jemds/26. [DOI] [Google Scholar]
- 10.Karigoudar RM, Karigoudar MH, Wavare SM, Mangalgi SS. Detection of biofilm among uropathogenic Escherichia coli and its correlation with antibiotic resistance pattern. J Lab Physicians. 2019;11(1):17–22. doi: 10.4103/JLP.JLP_98_18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Gun H, Lee SW, Carnicelli J, Jiang Z, Ren D. Antibiotic susceptibility of Escherichia coli cells during early-stage biofilm formation. J. Bacteriol. 2019;201(18):e00034-e19 N. doi: 10.1128/JB.00034-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Kim JS, Chowdhury N, Yamasaki R, Wood TK. Viable but non-culturable and persistence describe the same bacterial stress state. Environ Microbiol. 2018;20(6):2038–2048. doi: 10.1111/1462-2920.14075. [DOI] [PubMed] [Google Scholar]
- 13.Goormaghtigh F, FraikinN PM, Hallaert T, Hauryliak V. Reassessing the role of type II toxin- antitoxin systems in formation of Escherichia coli type II persister cells. MBio. 2018;9:e00640-18. doi: 10.1128/mBio.00640-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Masi M, Réfregiers M, Pos KM, Pagès JM. Mechanisms of envelope permeability and antibiotic influx and efflux in Gram negative bacteria. Nat. Microbiol. 2017;2:17001. doi: 10.1038/nmicrobiol.2017.1. [DOI] [PubMed] [Google Scholar]
- 15.Alav I, Sutton JM, Rahman KM. Role of bacterial efflux pumps in biofilm formation. J Antimicrob Chemother. 2018;73(8):2003–2020. doi: 10.1093/jac/dky042. [DOI] [PubMed] [Google Scholar]
- 16.Lebeaux D, Ghigo JM, Beloin C. Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. Microbiol Mol Boil Rev. 2014;78:510–554. doi: 10.1128/MMBR.00013-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Cardiliya AP, Selvaraj A, Nanjan MJ, Chandrasekar MJN. Plant based natural products as quorum sensing inhibitors in E. coli: a critical review. Mini Rev Med Chem. 2022;22(10):1380–1394. doi: 10.2174/1389557521666211101155150. [DOI] [PubMed] [Google Scholar]
- 18.Rezatofighi SE, Mirzarazi M, Salehi M. Virulence genes and phylogenetic groups of uropathogenic Escherichia coli isolates from patients with urinary tract infection and uninfected control subjects: a case-control study. BMC Infect Dis. 2021;17(1):361. doi: 10.1186/s12879-021-06036-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Wu H, Lee B, Yang L, Wang H, Givskov M, Molin S, et al. Effects of ginseng on Pseudomonas aeruginosa motility and biofilm formation. FEMS Immunol Med Microbiol. 2011;62:49–56. doi: 10.1371/journal.pone.0176883. [DOI] [PubMed] [Google Scholar]
- 20.Thangavelu S, Dhandapani R, Arulprakasam A, Paramasivam R, Chinnathambi A, Ali Alharbi S, Durairaj K, Shrestha A. Isolation, identification, characterization, and plasmid profile of urinary tract infectious Escherichia coli from clinical samples. Evid Based Complement Alternat Med. 2022;20:7234586. doi: 10.1155/2022/7234586. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- 21.Prakapaite R, Saab F, Planciuniene R, Petraitis V, Walsh TJ, Petraitiene R, et al. Molecular characterization of uropathogenic Escherichia coli reveals emergence of drug resistant O15, O22 and O25 serogroups. Medicina. 2019;55(11):733. doi: 10.3390/medicina55110733. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Hotchandani R, Aggarwal KK. Urinary tract infections in women. Indian J Clin Practice. 2012;23(4):187–194. doi: 10.18203/2394-6040.ijcmph20174274. [DOI] [Google Scholar]
- 23.Hooton TM, Scholes D, Stapleton AE, Roberts PL, Winter C, Gupta K, et al. (2000) A prospective study of asymptomatic bacteriuria in sexually active young women. N Eng J Med. 2000;343:992–997. doi: 10.1056/NEJM200010053431402. [DOI] [PubMed] [Google Scholar]
- 24.Kant S, Lohiya A, Kapil A, Gupta SK. Urinary tract infection among pregnant women at a secondary level hospital in Northern India. Indian J Public Health. 2017;61(2):118. doi: 10.4103/ijph.IJPH_293_15. [DOI] [PubMed] [Google Scholar]
- 25.Nitzan O, Elias M, Chazan B, Saliba W. Urinary tract infections in patients with type 2 diabetes mellitus: review of prevalence, diagnosis, and management. Diabetes Metab Syndr Obes. 2015;8:129–136. doi: 10.2147/DMSO.S51792. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Raya S, Belbase A, Dhakal L, Govinda Prajapati K, Baidya R, Kishor Bimali N. In-vitro biofilm formation and antimicrobial resistance of Escherichia coli in diabetic and nondiabetic patients. Biomed Res Int. 2019;2019:1474578. doi: 10.1155/2019/1474578. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Behzadi P, Urban E, Gajdacs M. Association between biofilm-production and antibiotic resistance in uropathogenic Escherichia coli (UPEC): an in vitro study. Diseases. 2020;8(2):17. doi: 10.3390/diseases8020017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Alizade H. Escherichia coli in Iran: an overview of antibiotic resistance: a review article. Iran J Public Health. 2018;47(1):1–12. [PMC free article] [PubMed] [Google Scholar]
- 29.Ho PL, Chu YP, Lo WU, Chow KH, Law PY, Tse CW, Ng TK, Cheng VC, Que TL. High prevalence of Escherichia coli sequence type 131 among antimicrobial-resistant E. coli isolates from geriatric patients. J Med Microbiol. 2015;64(3):243–247. doi: 10.1099/jmm.0.000012. [DOI] [PubMed] [Google Scholar]
- 30.Allami M, Bahreini M, Sharifmoghadam MR. Antibiotic resistance, phylogenetic typing, and virulence genes profile analysis of uropathogenic Escherichia coli isolated from patients in southern Iraq. J Appl Genet. 2022;63(2):401–412. doi: 10.1007/s13353-022-00683-2. [DOI] [PubMed] [Google Scholar]
- 31.Huang Z, Pan H, Zhang P, Cao X, Ju W, Wang C, Xu X. Prevalence and antimicrobial resistance patterns of diarrheagenic Escherichia coli in Shanghai. China. Pediatr Infect Dis J. 2016;35(8):835–839. doi: 10.1097/INF.0000000000001190. [DOI] [PubMed] [Google Scholar]
- 32.Themphachanal M, Kongpheng S, Rattanachuay P, Khianngam S, Singkhamanan K, Sukhumungoon P. Molecular characterization of virulence and antimicrobial susceptibility profiles of uropathogenic Escherichia coli from patients in a tertiary hospital, southern Thailand. Southeast Asian J Trop Med Public Health. 2015;46(6):1021–1030. [PubMed] [Google Scholar]
- 33.Qian W, Li X, Yang M, Liu C, Kong Y, Li Y, et al. Relationship between antibiotic resistance, biofilm formation, and biofilm-specific resistance in Escherichia coli isolates from Ningbo, China. Infect Drug Resist. 2022;15:2865–2878. doi: 10.2147/IDR.S363652. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Pompilio A, Crocetta V, Savini V, Petrelli D, Di Nicola M, Bucco S. Phylogenetic relationships, biofilm formation, motility, antibiotic resistance and extended virulence genotypes among Escherichia coli strains from women with community-onset primitive acute pyelonephritis. PLoS ONE. 2018;13(5):e0196260. doi: 10.1371/journal.pone.0196260. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Contreras-Alvarado LM, Zavala-Vega S, Cruz-Córdova A, Reyes-Grajeda JP, Escalona-Venegas G, et al. Uropathogenic Escherichiacoli O25b strains associated with complicated urinary tract infection in children. Microorganisms. 2021;9:2299. doi: 10.3390/microorganisms9112299. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Bajpai T, Varma M, Bhatambare GS, Pandey M. Escherichia coli biofilms: accepting the therapeutic challenges. Int J Health Allied Sci. 2016;5(4):204. doi: 10.4103/2278-344X.194081. [DOI] [Google Scholar]
- 37.Shah C, Baral R, Bartaula B. Virulence factors of uropathogenic Escherichia coli (UPEC) and correlation with antimicrobial resistance. BMC Microbiol. 2019;19:204. doi: 10.1186/s12866-019-1587-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Pereira B, Kulkarni S. Antibiotic misuse and improper practices in India: identifying the scope to improve through a narrative review. Int J Risk Saf Med. 2022;33(4):357–364. doi: 10.3233/JRS-210020. [DOI] [PubMed] [Google Scholar]
- 39.Karam MRA, Habibi M, Bouzari S. Relationships between virulence factors and antimicrobial resistance among Escherichia coli isolated from urinary tract infections and commensal isolates in Tehran, Iran. Osong Public Health Res Perspect. 2018;9(5):217–224. doi: 10.24171/j.phrp.2018.9.5.02. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Terlizzi ME, Gribaudo G, Maffei ME. Uropathogenic Escherichia coli (UPEC) infections: virulence factors bladder responses, antibiotic and nonantibiotic antimicrobial strategies. Front Microbio. 2017;l8:1566. doi: 10.3389/fmicb.2017.01566. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Nakamura Y, Yamamoto N, Kino Y, Yamamoto N, Kamei S, Mori H. Establishment of a multi-species biofilm model and metatranscriptomic analysis of biofilm and planktonic cell communities. Appl Microbial Biotechnol. 2016;100:7263–7279. doi: 10.1007/s00253-016-7532-6. [DOI] [PubMed] [Google Scholar]
- 42.Magray MS, Kumar A, Rawat AK, Srivastava S. Identification of Escherichia coli through analysis of 16S rRNA and 16S-23S rRNA internal transcribed spacer region sequences. Bioinformation. 2011;6(10):370. doi: 10.6026/97320630006370. [DOI] [PMC free article] [PubMed] [Google Scholar]



